Parasitic worms of pigs could provide new treatments of human diseases « New Drug Approvals

Parasitic worms of pigs could provide new treatments of human diseases « New Drug Approvals:



'via Blog this'

Lung-MAP Launches: First Precision Medicine Trial From National Clinical Trials Network « New Drug Approvals

Lung-MAP Launches: First Precision Medicine Trial From National Clinical Trials Network « New Drug Approvals:



'via Blog this'

A new twist on neuro disease: Discovery could aid people with dystonia, Parkinson’s and more « New Drug Approvals

A new twist on neuro disease: Discovery could aid people with dystonia, Parkinson’s and more « New Drug Approvals:



'via Blog this'

Provectus Phase III Melanoma Trial Results Earlier Than Planned? « New Drug Approvals

Provectus Phase III Melanoma Trial Results Earlier Than Planned? « New Drug Approvals:



'via Blog this'

Pharma vies to unleash immune system power on cancer « New Drug Approvals

Pharma vies to unleash immune system power on cancer « New Drug Approvals:



'via Blog this'

Selexipag Meets Primary Endpoint in Pivitol Phase III Griphon Outcome Study in Patients with Pulmonary Arterial Hypertension « New Drug Approvals

Selexipag Meets Primary Endpoint in Pivitol Phase III Griphon Outcome Study in Patients with Pulmonary Arterial Hypertension « New Drug Approvals:



'via Blog this'

The USFDA has approved Navidea Biopharmaceuticals’ Supplemental New Drug Application (sNDA) for the expanded use of Lymphoseek (technetium Tc 99m tilmanocept) Injection « New Drug Approvals

The USFDA has approved Navidea Biopharmaceuticals’ Supplemental New Drug Application (sNDA) for the expanded use of Lymphoseek (technetium Tc 99m tilmanocept) Injection « New Drug Approvals:



'via Blog this'